Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 298, Issue 7, Pages 102139
Publisher
Elsevier BV
Online
2022-06-14
DOI
10.1016/j.jbc.2022.102139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human glutaredoxin-1 can transfer copper to isolated metal binding domains of the P1B-type ATPase, ATP7B
- (2020) Shadi Maghool et al. Scientific Reports
- Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice
- (2020) Liam M. Guthrie et al. SCIENCE
- Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders
- (2020) Vishal M. Gohil EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Elesclomol restores mitochondrial function in genetic models of copper deficiency
- (2018) Shivatheja Soma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chelating principles in Menkes and Wilson diseases
- (2018) Nina Horn et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Potassium and the K+/H+Exchanger Kha1p Promote Binding of Copper to ApoFet3p Multi-copper Ferroxidase
- (2016) Xiaobin Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutations inCOA6cause CytochromecOxidase Deficiency and Neonatal Hypertrophic Cardiomyopathy
- (2014) Fabian Baertling et al. HUMAN MUTATION
- Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment
- (2014) Stephen G. Kaler JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol
- (2013) Shoujun Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II)
- (2013) Arun A. Yadav et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Multi-Copper Oxidases and Human Iron Metabolism
- (2013) Ganna Vashchenko et al. Nutrients
- Charting the travels of copper in eukaryotes from yeast to mammals
- (2012) Tracy Nevitt et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
- (2012) Hiroko Kodama et al. CURRENT DRUG METABOLISM
- The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
- (2012) Masazumi Nagai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
- (2012) Ronald K. Blackman et al. PLoS One
- Copper: An essential metal in biology
- (2011) Richard A. Festa et al. CURRENT BIOLOGY
- Knocking out multigene redundancies via cycles of sexual assortment and fluorescence selection
- (2011) Yo Suzuki et al. NATURE METHODS
- ATP7A-related copper transport diseases—emerging concepts and future trends
- (2011) Stephen G. Kaler Nature Reviews Neurology
- LC–MS/MS and density functional theory study of copper(II) and nickel(II) chelating complexes of elesclomol (a novel anticancer agent)
- (2010) Lianming Wu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Menkes disease
- (2009) Zeynep Tümer et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Human copper transporters: mechanism, role in human diseases and therapeutic potential
- (2009) Arnab Gupta et al. Future Medicinal Chemistry
- Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma
- (2009) Steven O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Elesclomol induces cancer cell apoptosis through oxidative stress
- (2008) J. R. Kirshner et al. MOLECULAR CANCER THERAPEUTICS
- Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes
- (2008) Subba Rao Gangi Setty et al. NATURE
- Mechanisms for copper acquisition, distribution and regulation
- (2008) Byung-Eun Kim et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now